Lupus drug benlysta proves safe and effective in Real-World study of over 1,500 patients
NCT ID NCT03370263
First seen Feb 01, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This study looked at how safe and effective Benlysta is for people with lupus when used in normal medical practice. Over 1,500 patients were followed for one year. Researchers tracked side effects, disease activity, and quality of life to ensure the drug works well outside of controlled trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Hiroshima, 730-0001, Japan
Conditions
Explore the condition pages connected to this study.